Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
Orthox, a UK-based developer of medical implants for repairing orthopaedic injuries such as damaged knee articular cartilage, has added $4.3m to its series A round for a $12.5m close. The round was led by Parkwalk Advisors, the fund management arm of commercialisation firm IP Group, as well as Oxford Technology and Innovations EIS Fund, Perivoli Innovations and Additio Investment Group as well as undisclosed new investors. Spun out of University of Oxford in 2008, Orthox had previously raised a total of £6m ($8.1m at current exchange rates), according to accounts made up to February 2021.
Ababa, a Japan-based operator of an online recruitment service focused on recent graduates spun out of Okayama University, raised ¥60m ($520,000) in seed funding on Tuesday from investors including human resources provider Will Group’s HRTech Fund 2, Setouchi Startups Fund 1 and unnamed angel investors.
Perturba Therapeutics, a Canada-based developer of assets from undrugged protein-protein interactions, was spun out of the Stagljar Lab at University of Toronto yesterday. The company was established through the support of Cyclica, a biotech company that focuses on collaborations and joint ventures with academic institutions and pharmaceutical companies.
– Additional reporting by Liwen-Edison Fu
